Nandan Shah, director, clinical development and regulatory affairs at Regeneron Pharmaceuticals, talks to contributing editor Tanuja Koppal, PhD, about the big trends that are likely to impact informatics and data analysis in the clinical world.
Compound kushen injection (CKI) is approved for use in China to treat various cancer tumors, usually as an adjunct to western chemotherapy—but how it works has not been known
The chemists attach luminescent compounds to tiny gold structures to form biologically safe ‘nanoagents’ that are attracted to calcium-rich surfaces, which appear when bones crack—even at a micro level